Severe Perivalvular Abscess After ViV-TAVR for Infective Endocarditis Following SAVR Accompanied Multiple Comorbidities
ViV-TAVR may be an option in high-risk patients with healed IE, provided infection resolution is clearly established. Postoperative anti-infective therapy should be optimized individually based on comorbidities and infection history. Diabetes may be a risk factor for poorer outcomes in such cases.
Authors
- Lianyue Ma (ORCID: https://orcid.org/0000-0002-6609-6338)
- Meng Xiao (ORCID: https://orcid.org/0000-0003-2103-7008)
- Xiangjuan Liu (ORCID: https://orcid.org/0000-0002-8911-3399)
- Yuan Cao (ORCID: https://orcid.org/0009-0004-8130-2576)
- Dandan Wang (ORCID: https://orcid.org/0000-0001-6227-1250)
- Yan Liu (ORCID: https://orcid.org/0000-0002-4672-1837)
- Guipeng An (ORCID: https://orcid.org/0000-0002-1757-0849)
Institutions
- Shandong University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Ministry of Education (TH)
- Ministry of Education (BD)
- Qilu Hospital of Shandong University (CN)
Publication Details
- Journal
- JACC Case Reports
- Published
- 2025-11-23
- DOI
- https://doi.org/10.1016/j.jaccas.2025.106351
- Primary Topic
- Infective Endocarditis Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00